Literature DB >> 10624454

Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study.

M A Krieg1, A F Jacquet, M Bremgartner, S Cuttelod, D Thiébaud, P Burckhardt.   

Abstract

Supplementation of elderly institutionalized women with vitamin D and calcium decreased hip fractures and increased hip bone mineral density. Quantitative ultrasound (QUS) measurements can be performed in nursing homes, and easily repeated for follow-up. However, the effect of the correction of vitamin D deficiency on QUS parameters is not known. Therefore, 248 institutionalized women aged 62-98 years were included in a 2-year open controlled study. They were randomized into a treated group (n = 124), receiving 440 IU of vitamin D3 combined with 500 mg calcium (1250 mg calcium carbonate, Novartis) twice daily, and a control group (n = 124). One hundred and three women (42%), aged 84.5 +/- 7.5 years, completed the study: 50 in the treated group, 53 in the controls. QUS of the calcaneus, which measures BUA (broadband ultrasound attenuation) and SOS (speed of sound), and biochemical analysis were performed before and after 1 and 2 years of treatment. Only the results of the women with a complete follow-up were taken into account. Both groups had low initial mean serum 25-hydroxyvitamin D levels (11.9 +/- 1.2 and 11.7 +/- 1.2 micrograms/l; normal range 6.4-40.2 micrograms/l) and normal mean serum parathyroid hormone (PTH) levels (43.1 +/- 3.2 and 44.6 +/- 3.5 ng/l; normal range 10-70 ng/l, normal mean 31.8 +/- 2.3 ng/l). The treatment led to a correction of the metabolic disturbances, with an increase in 25-hydroxyvitamin D by 123% (p < 0.01) and a decrease in PTH by 18% (p < 0.05) and of alkaline phosphatase by 15% (p < 0.01). In the controls there was a worsening of the hypovitaminosis D, with a decrease of 25-hydroxyvitamin D by 51% (p < 0.01) and an increase in PTH by 51% (p < 0.01), while the serum calcium level decreased by only 2% (p < 0.01). After 2 years of treatment BUA increased significantly by 1.6% in the treated group (p < 0.05), and decreased by 2.3% in the controls (p < 0.01). Therefore, the difference in BUA between the treated subjects and the controls (3.9%) was significant after 2 years (p < 0.01). However, SOS decreased by the same amount in both groups (approximately 0.5%). In conclusion, BUA, but not SOS, reflected the positive effect on bone of supplementation with calcium and vitamin D3 in a population of elderly institutionalized women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624454     DOI: 10.1007/s001980050265

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

1.  Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

Authors:  D Stoll; J Dudler; O Lamy; D Hans; M A Krieg; B Aubry-Rozier
Journal:  Osteoporos Int       Date:  2012-03-17       Impact factor: 4.507

Review 2.  The use of ultrasound in the assessment of bone status.

Authors:  S Gonnelli; C Cepollaro
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis.

Authors:  S Gonnelli; G Martini; C Caffarelli; S Salvadori; A Cadirni; A Montagnani; R Nuti
Journal:  Osteoporos Int       Date:  2006-06-09       Impact factor: 4.507

4.  Relationship between vitamin D, parathyroid hormone, and bone health.

Authors:  A J Sai; R W Walters; X Fang; J C Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

5.  Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review.

Authors:  Kazutoshi Nakamura; Masayuki Iki
Journal:  Environ Health Prev Med       Date:  2006-07       Impact factor: 3.674

Review 6.  Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.

Authors:  Y Rolland; P de Souto Barreto; G Abellan Van Kan; C Annweiler; O Beauchet; H Bischoff-Ferrari; G Berrut; H Blain; M Bonnefoy; M Cesari; G Duque; M Ferry; O Guerin; O Hanon; B Lesourd; J Morley; A Raynaud-Simon; G Ruault; J-C Souberbielle; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

7.  Quantitative ultrasound measurements of bone: measurement error, discordance, and their effects on longitudinal studies.

Authors:  J Zochling; T V Nguyen; L M March; P N Sambrook
Journal:  Osteoporos Int       Date:  2004-02-13       Impact factor: 4.507

8.  Efficacy of a Standardized Oral Vitamin D Dosing Regimen in Nursing Home Residents.

Authors:  Marlous Toren-Wielema; Ruth Veenhuizen; Jan Willem Kappelle; Nic Veeger; Eric van Roon
Journal:  Drugs Aging       Date:  2018-12       Impact factor: 3.923

9.  Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials.

Authors:  Lars Rejnmark; Alison Avenell; Tahir Masud; Frazer Anderson; Haakon E Meyer; Kerrie M Sanders; Kari Salovaara; Cyrus Cooper; Helen E Smith; Elizabeth T Jacobs; David Torgerson; Rebecca D Jackson; JoAnn E Manson; Kim Brixen; Leif Mosekilde; John A Robbins; Roger M Francis; Bo Abrahamsen
Journal:  J Clin Endocrinol Metab       Date:  2012-05-17       Impact factor: 5.958

10.  Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline.

Authors:  Malachi J McKenna; Barbara F Murray
Journal:  Endocr Connect       Date:  2013-04-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.